Follow
Caroline Guignant
Caroline Guignant
Unknown affiliation
Verified email at chu-nantes.fr
Title
Cited by
Cited by
Year
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients
C Guignant, A Lepape, X Huang, H Kherouf, L Denis, F Poitevin, ...
Critical care 15 (2), R99, 2011
3352011
Early assessment of leukocyte alterations at diagnosis of septic shock
F Venet, F Davin, C Guignant, A Larue, MA Cazalis, R Darbon, ...
Shock 34 (4), 358-363, 2010
2102010
Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma
A Cheron, B Floccard, B Allaouchiche, C Guignant, F Poitevin, C Malcus, ...
Critical Care 14 (6), R208, 2010
1842010
Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma
A Gouel-Chéron, B Allaouchiche, C Guignant, F Davin, B Floccard, ...
PloS one 7 (3), e33095, 2012
1622012
Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients
C Guignant, N Voirin, F Venet, F Poitevin, C Malcus, J Bohé, A Lepape, ...
Intensive care medicine 35 (11), 1859, 2009
1302009
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients
L Zabijak, C Attencourt, C Guignant, D Chatelain, P Marcelo, ...
Cancer immunology, immunotherapy 64 (12), 1601-1608, 2015
1132015
Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients
F Venet, R Gebeile, J Bancel, C Guignant, F Poitevin-Later, C Malcus, ...
International immunopharmacology 11 (12), 2086-2090, 2011
962011
Th17 and CD24 hi CD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis
S Salomon, C Guignant, P Morel, G Flahaut, C Brault, C Gourguechon, ...
Arthritis research & therapy 19 (1), 33, 2017
502017
Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab
H Thiebault, P Boyard-Lasselin, C Guignant, N Guillaume, A Wacrenier, ...
European journal of gastroenterology & hepatology 28 (8), 876-881, 2016
412016
Increased MerTK expression in circulating innate immune cells of patients with septic shock
C Guignant, F Venet, S Planel, J Demaret, A Gouel-Chéron, C Nougier, ...
Intensive care medicine 39 (9), 1556-1564, 2013
342013
Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients
F Turrel-Davin, C Guignant, A Lepape, B Mougin, G Monneret, F Venet
Critical Care 14 (4), R133, 2010
312010
Persistent high level of circulating midregional-proadrenomedullin and increased risk of nosocomial infections after septic shock
C Guignant, N Voirin, F Venet, A Lepape, G Monneret
Journal of Trauma and Acute Care Surgery 72 (1), 293-296, 2012
172012
Innovative therapeutic strategies for restoring lymphocyte functions in septic patients
F Turrel, C Guignant, F Venet, A Lepape, G Monneret
Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2008
172008
Flow cytometry developments and perspectives in clinical studies: examples in ICU patients
F Venet, C Guignant, G Monneret
Cell Cycle Synchronization, 261-275, 2011
152011
Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1
C Guignant, F Venet, N Voirin, F Poitevin, C Malcus, J Bohé, A Lepape, ...
Clinical chemistry and laboratory medicine 48 (12), 1813-1820, 2010
122010
Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells
H Ghamlouch, W Darwiche, A Hodroge, H Ouled-Haddou, S Dupont, ...
Oncotarget 6 (21), 18484, 2015
102015
Assessment of cellular immune parameters in paediatric toxic shock syndrome: a report of five cases
O Dauwalder, F Venet, E Javouhey, C Badiou, Y Gillet, C Guignant, ...
FEMS Immunology & Medical Microbiology 66 (1), 116-119, 2012
52012
The Baseline Th17 Lymphocytes Level Is a Predictive Marker of Good Response to Biologics in Rheumatoid Arthritis
S Salomon, C Guignant, P Morel, B Gubler, P Fardellone, JP Marolleau, ...
ARTHRITIS & RHEUMATOLOGY 68, 2016
2016
AB0025 Evolution of Regulatory B Cells under Treatment by Biologics in Rheumatoid Arthritis
S Salomon, C Guignant, C Brault, G Flahaut, B Gubler, P Fardellone, ...
Annals of the Rheumatic Diseases 75, 905, 2016
2016
Lymphocytose polyclonale à lymphocytes binucléés: une cause de déficit immunitaire humoral?
C Guignant, A Mambie, M Diouf, C Roumier, C Roche-Lestienne, ...
La Revue de Médecine Interne 37, A49-A50, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20